The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib. Kittai AS, Miller C, Goldstein D, Huang Y, et al. Blood 2021;138:2372-2382.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kittai AS, Miller C, Goldstein D, Huang Y, et al. The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib. Blood 2021;138:2372-2382.
PMID: 34314481